Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page adds a recruitment status note indicating no longer looking for participants and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study); it also reformats the 'Intervention / Treatment' label to 'Intervention/Treatment' and updates the revision tag to v3.6.0.SummaryDifference0.4%

- Check10 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates an updated version of the page’s documentation/assets.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a new revision in the revision history. This update does not alter the content or behavior of the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision has been updated from v3.5.2 to v3.5.3, reflecting a new template release. It does not change the displayed study details or layout for users.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0. This appears to be a minor site update with no changes to study records.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision indicator updated to v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.